Johnson Matthey (LON:JMAT)‘s stock had its “buy” rating reiterated by investment analysts at Deutsche Bank in a research note issued on Wednesday, January 31st. They currently have a GBX 3,800 ($53.28) target price on the stock. Deutsche Bank’s price target would indicate a potential upside of 22.19% from the stock’s current price.
Other equities research analysts also recently issued research reports about the company. Credit Suisse Group reissued an “outperform” rating and set a GBX 3,900 ($54.68) price target on shares of Johnson Matthey in a research report on Thursday, February 1st. Liberum Capital reissued a “hold” rating and set a GBX 3,400 ($47.67) price target on shares of Johnson Matthey in a research report on Wednesday, January 17th. Morgan Stanley boosted their price objective on Johnson Matthey from GBX 3,500 ($49.07) to GBX 3,900 ($54.68) and gave the stock an “overweight” rating in a research note on Monday, November 13th. JPMorgan Chase & Co. restated a “neutral” rating and set a GBX 3,400 ($47.67) price objective on shares of Johnson Matthey in a research note on Wednesday, November 22nd. Finally, Barclays restated an “overweight” rating and set a GBX 3,680 ($51.60) price objective (up previously from GBX 3,450 ($48.37)) on shares of Johnson Matthey in a research note on Thursday, November 16th. One investment analyst has rated the stock with a sell rating, two have assigned a hold rating and six have given a buy rating to the company’s stock. Johnson Matthey has a consensus rating of “Buy” and a consensus target price of GBX 3,592.22 ($50.37).
Johnson Matthey (LON:JMAT) traded down GBX 141 ($1.98) during midday trading on Wednesday, hitting GBX 3,110 ($43.61). The stock had a trading volume of 2,290,472 shares, compared to its average volume of 705,562. Johnson Matthey has a 12 month low of GBX 2,681 ($37.59) and a 12 month high of GBX 3,511 ($49.23). The firm has a market capitalization of $6,020.00 and a PE ratio of 1,636.84.
Johnson Matthey (LON:JMAT) last announced its quarterly earnings data on Tuesday, November 21st. The company reported GBX 99.80 ($1.40) EPS for the quarter, missing the Zacks’ consensus estimate of GBX 100.10 ($1.40) by GBX (0.30) ($0.00). The business had revenue of GBX 647.83 billion during the quarter. Johnson Matthey had a net margin of 2.60% and a return on equity of 14.99%.
In related news, insider Robert MacLeod bought 12 shares of the stock in a transaction dated Wednesday, January 17th. The stock was bought at an average cost of GBX 3,273 ($45.89) per share, with a total value of £392.76 ($550.70).
COPYRIGHT VIOLATION NOTICE: “Johnson Matthey (JMAT) Rating Reiterated by Deutsche Bank” was first reported by The Ledger Gazette and is owned by of The Ledger Gazette. If you are reading this piece of content on another publication, it was illegally stolen and republished in violation of United States & international trademark and copyright legislation. The correct version of this piece of content can be read at https://ledgergazette.com/2018/02/11/johnson-matthey-jmat-earns-buy-rating-from-deutsche-bank.html.
Johnson Matthey Company Profile
Johnson Matthey Plc is a specialty chemicals company. The Company operates in five divisions: Emission Control Technologies, which is a manufacturer of catalysts and catalyst systems for vehicles and industry; Process Technologies, which is a supplier of catalysts, licensing technologies and other services to the syngas, oleo/biochemical, petrochemical, oil refining and gas processing industries; Precious Metal Products, which is organized into its Services businesses, which include management, distribution, refining and recycling of precious metals, and its Manufacturing businesses, which fabricates products using precious metals or related materials, platinum group metal catalysts and platinum group metal chemicals; Fine Chemicals, which is a supplier of active pharmaceutical ingredients (API), custom services and catalyst technologies, and New Businesses, which focuses on its Battery Technologies, Atmosphere Control Technologies and Fuel Cells Businesses.
Receive News & Ratings for Johnson Matthey Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Johnson Matthey and related companies with MarketBeat.com's FREE daily email newsletter.